SEC Form 4 · accession 0000313143-15-000018
HAEMONETICS CORP · HAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronald G Gelbman
Director
Period of report
Mar 5, 2015
Accepted (ET)
Mar 6, 2015 · 2:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000313143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 5, 2015 | M | 11,328 | $29.23 | A | 52,895 | D | |
| Common Stock | Mar 5, 2015 | S | 7,707 | $44.7562 | D | 45,188 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1 | $29.23 | Mar 5, 2015 | M | 11,328 | D | Jul 31, 2009 | Jul 31, 2015 | Common Stock | 11,328 | 0 | D |
Explanation of responses
- F1Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.